U.S. Online Retail and Ecommerce Stock News

NYSE:OFG
NYSE:OFGBanks

Does OFG Bancorp’s (OFG) Bigger Buyback Reveal Its True Capital Allocation Priorities?

OFG Bancorp recently announced that its Board of Directors approved a new open-ended US$200 million stock repurchase authorization and raised the regular quarterly cash dividend by 17% to US$0.35 per share, payable on April 15, 2026, to shareholders of record on March 31, 2026. These capital actions, coming alongside the completion of a prior buyback program and higher quarterly earnings, highlight management’s current focus on returning excess capital to shareholders. Against this backdrop,...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

F5 (FFIV) Net Margin Strength Reinforces Bullish Narratives Despite Modest Growth Forecasts

F5 (FFIV) has just opened its Q1 2026 scorecard with revenue of US$822.5 million and basic EPS of US$3.12, framed against trailing 12 month revenue of about US$3.1 billion and EPS of US$12.23. Over the past year, the company has seen quarterly revenue move from US$766.5 million in Q1 2025 through US$810.1 million in Q4 2025 to US$822.5 million in the latest quarter, while basic EPS tracked from US$2.85 to US$3.30 and now US$3.12. Taken together, this sets up a picture of solid scale with...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

Is Pebblebrook Hotel Trust (PEB) A Potential Opportunity After Prolonged Share Price Weakness?

If you are wondering whether Pebblebrook Hotel Trust is priced attractively right now, this article will walk through what the current share price could mean for long term investors. The stock last closed at US$11.31, with returns of an 8.9% decline over 7 days, a 1.5% decline over 30 days, a 2.1% decline year to date, a 14.8% decline over 1 year, a 31.8% decline over 3 years, and a 42.6% decline over 5 years. Recent price moves are often influenced by changing expectations around the hotel...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Is Vera Therapeutics (VERA) Attractive After Recent Share Price Pullback And DCF Upside?

If you are wondering whether Vera Therapeutics at around US$45 a share still offers value, the key question is how its current price compares with what the business might reasonably be worth. The stock has seen a mixed run, with an 18.9% return over the past year but declines of 1.4% over the last week, 13.7% over the last month and 7.2% year to date. This can change how the market views both its potential and its risks. Recent attention on Vera Therapeutics has largely centered on its drug...
OTCPK:FMCC
OTCPK:FMCCDiversified Financial

Freddie Mac Securitization Update Highlights Valuation Gap And Ongoing Risks

Freddie Mac OTCPK:FMCC released its Monthly Volume Summary for December 2025, detailing recent activity across its mortgage portfolio. New preliminary ratings were assigned by KBRA to Freddie Mac mortgage pass through certificates, linked to recent securitization activity. The latest Monthly Volume Summary provides a closer look at how Freddie Mac is managing its book of mortgages, including guarantees and securitizations. As a government sponsored enterprise focused on housing finance, the...
NasdaqGS:CFFI
NasdaqGS:CFFIBanks

C&F Financial (CFFI) Margin Improvement Reinforces Bullish Narratives Despite Mixed Long Term Earnings

C&F Financial (CFFI) has wrapped up FY 2025 with fourth quarter total revenue of US$32.3 million and basic EPS of US$2.07, while trailing twelve month revenue came in at US$129.3 million and EPS at US$8.34, alongside 36.1% earnings growth over the year. Over recent quarters, total revenue has moved from US$28.5 million in Q4 2024 to US$34.3 million in Q2 2025 before settling at US$32.3 million in Q4 2025, with quarterly EPS ranging from US$1.66 in Q1 2025 to US$2.37 in Q2 2025. With net...
NYSE:UNM
NYSE:UNMInsurance

Is It Too Late To Revisit Unum Group (UNM) After Its Strong Multi‑Year Rally?

If you are wondering whether Unum Group at around US$76 a share still offers solid value after its long run, this article will walk through what the current price might be implying. The stock has barely moved over the last year with a 0.4% return, even after a very strong 3 year return of about 90% and a very large 5 year gain that is close to 3x. Recent attention on Unum Group has largely focused on its position as a US life and disability insurer, with investors weighing how its risk...
NYSE:GNL
NYSE:GNLREITs

Is It Too Late To Consider Global Net Lease (GNL) After Its 47% One-Year Rally?

Wondering if Global Net Lease is genuinely good value at around US$9.39 a share, or if the recent run means you are late to the story. The stock has had a mixed return profile, with a 1.9% decline over the last 7 days, a 10.5% gain over the last 30 days, a 6.5% gain year to date, a 47.1% return over 1 year, a 7.5% decline over 3 years and a 2.2% return over 5 years. These swings in returns can reflect changing views on Global Net Lease's real estate portfolio and income profile. They also...
NYSE:FCF
NYSE:FCFBanks

Is It Time To Reassess First Commonwealth Financial (FCF) After Recent Share Price Moves?

If you are wondering whether First Commonwealth Financial's share price still reflects fair value, you are not alone. Many investors are asking the same question before making their next move. The stock recently closed at US$17.60, with returns of 3.1% over 30 days, 4.9% year to date and 12.6% over 1 year, while the 7 day return was a 2.8% decline and the 3 and 5 year returns were 32.0% and 72.1% respectively. These moves are set against a backdrop of ongoing sector wide attention on...
NYSE:PVH
NYSE:PVHLuxury

Is PVH (PVH) Now Attractive After A 33% One Year Share Price Decline

If you are wondering whether PVH is priced attractively right now, it helps to step back and look at how the current share price lines up with a few different valuation yardsticks. The stock last closed at US$61.23, with returns of a 1.7% decline over 7 days, 10.2% decline over 30 days, 9.7% decline year to date, 33.2% decline over 1 year, 33.9% decline over 3 years and 29.6% decline over 5 years. This naturally raises questions about whether expectations or perceived risk have...
NYSE:FBP
NYSE:FBPBanks

First BanCorp (FBP) Net Margin Strength Reinforces Bullish Narratives After FY 2025 Results

First BanCorp (FBP) has wrapped up FY 2025 with fourth quarter total revenue of US$234.2 million and EPS of US$0.56, rounding out a trailing twelve month revenue line of US$914.9 million and EPS of US$2.16. Over the past few quarters, the company has seen revenue move from US$222.1 million in Q4 2024 to US$234.2 million in Q4 2025, while quarterly EPS has shifted from US$0.46 to US$0.56. This gives investors a clearer read on how the earnings profile is tracking into the current year. With...
NYSE:NEE
NYSE:NEEElectric Utilities

NextEra Energy (NEE) Margin Compression Challenges Bullish Growth Narrative After FY 2025 Results

NextEra Energy (NEE) has wrapped up FY 2025 with fourth quarter revenue of US$6.5 billion and basic EPS of US$0.73, alongside trailing 12 month revenue of US$27.4 billion and EPS of US$3.30 that sit against a lower net profit margin than a year earlier. The company has seen quarterly revenue move from US$5.4 billion in Q4 2024 to US$6.5 billion in Q4 2025, while Q4 EPS shifted from US$0.58 to US$0.73. Full year net income for the latest trailing period was US$6.8 billion compared with US$6.9...
NasdaqCM:FNWD
NasdaqCM:FNWDBanks

Finward Bancorp (FNWD) Net Margin Drop Challenges Bullish Earnings Growth Narrative

Finward Bancorp (FNWD) has rounded out FY 2025 with fourth quarter revenue of US$16.6 million and basic EPS of US$0.46. Trailing twelve month revenue came in at US$66.2 million with EPS of US$1.89. The company has seen quarterly revenue move from US$14.9 million in Q3 FY 2024 to the mid US$16 million range through FY 2025. Basic EPS has ranged from US$0.11 in Q1 FY 2025 to US$0.82 in Q3 before landing at US$0.46 in Q4. This sets up an earnings season where investors are likely to focus on how...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Is It Too Late To Consider Amneal Pharmaceuticals (AMRX) After Its Strong Multi Year Run?

If you are wondering whether Amneal Pharmaceuticals is still priced attractively after its recent run, you are not alone. The stock last closed at US$13.95, with returns of 1.8% over 7 days, 8.1% over 30 days, 10.2% year to date, 59.8% over 1 year, and a very large 3 year return alongside a 183.5% return over 5 years. Recent coverage has focused on Amneal Pharmaceuticals as investors reassess the company and its place in the US pharmaceuticals and biotech space. These developments give extra...
NYSE:GM
NYSE:GMAuto

GM (GM) Q4 Loss And 1.7% Margin Keep Profitability Concerns In Focus

General Motors (GM) closed FY 2025 with Q4 revenue of US$45.3b and a loss per share of US$3.60, as net income excluding extra items came in at a loss of US$3.3b. Across the year, revenue has moved between US$44.0b in Q1 and US$48.6b in Q3, while EPS ranged from US$3.40 in Q1 to US$1.37 in Q3 before swinging to a loss in Q4. This set up a year where the full trailing twelve months delivered Basic EPS of US$3.33 on revenue of US$185.0b. With trailing net margins at 1.7% versus 3.8% a year...
NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Strive Asset Management Resets Board To Support Growth And Governance

Strive Asset Management (NasdaqGM:ASST) has reshaped its corporate governance structure with several leadership and board changes. Avik Roy is transitioning into the role of Chief Strategy Officer, shifting his focus toward broader firm wide priorities. Eric Semler has joined the board, along with adjustments to key board committees tied to capital allocation, digital assets, and public policy. For you as an investor, these moves at NasdaqGM:ASST come at a time when asset managers are...
NYSE:NRG
NYSE:NRGElectric Utilities

NRG Energy’s LS Power Deal Tests Growth, Cash Returns And New Leadership

NRG Energy (NYSE:NRG) has received final antitrust and regulatory approvals for its acquisition of LS Power assets. The deal includes 18 natural gas generation facilities and a commercial and industrial virtual power plant platform. The company announced an 8% dividend increase alongside the approvals. NRG Energy also named a new CEO to lead the business following the transaction. NRG Energy enters this news with its shares at $155.11 and a very large 3-year return, around 4x, and a 5-year...
NasdaqCM:BTBT
NasdaqCM:BTBTSoftware

Assessing Bit Digital (BTBT) Valuation As Earnings Forecasts Show Smaller Loss And Revenue Growth

Why Bit Digital (BTBT) is on investors’ radar right now Bit Digital (BTBT) is drawing attention as it heads into an earnings report, where the company is expected to post a loss of $0.02 per share and 17.48% revenue growth year over year. See our latest analysis for Bit Digital. Bit Digital’s recent trading has been choppy, with a 7.46% 1 month share price return and a 38.98% 3 month share price decline. Its 1 year total shareholder return of 29.18% and 3 year total shareholder return of 35%...